The UCW Newswire : Blockchain and Crypto News
  • MAIN
  • ABOUT
  • RSS FEED
  • FINANCIAL NEWS
  • X
  • MCHATHIVE
Close
  • Home
  • Bio-Pharma
Category : Bio-Pharma
Digital Asset Treasuries Could Be the Lifeline Lower-Middle Market Biotech Firms Need
Bio-Pharma Biotech Cryptocurrency Digital Assets Financial Markets Global Markets
July 24, 2025

Digital Asset Treasuries Could Be the Lifeline Lower-Middle Market Biotech Firms Need

Alpenglow Biosciences and Mayo Clinic enter collaboration agreement to advance pathology and drug development through 3D spatial biology
Bio-Pharma Biotech Medical Venutre Capital
April 13, 2023

Alpenglow Biosciences and Mayo Clinic enter collaboration agreement to advance pathology and drug development through 3D spatial biology

Female-owned biotech startup, Tiamat Sciences raise an extension of $2M to accelerate product validation and strategic partnerships
Bio-Pharma Biotech Medical Startups Technology
March 9, 2023

Female-owned biotech startup, Tiamat Sciences raise an extension of $2M to accelerate product validation and strategic partnerships

Avicanna Announces Organizational Change in Avicanna LATAM S.A.S
Bio-Pharma Cannabis Medical Stock Market
December 30, 2022

Avicanna Announces Organizational Change in Avicanna LATAM S.A.S

Biomind Labs Announces the Completion of the First Sublingual Psychedelic Formulation for Its Drug Candidate BMND08 for Depression and Anxiety in Alzheimer’s Disease
Bio-Pharma Medical Technology
December 29, 2022

Biomind Labs Announces the Completion of the First Sublingual Psychedelic Formulation for Its Drug Candidate BMND08 for Depression and Anxiety in Alzheimer’s Disease

Optimi Health Appoints Principal Investigator for Clinical Dosing Study
Bio-Pharma Business Medical Stock Market
October 19, 2021

Optimi Health Appoints Principal Investigator for Clinical Dosing Study

ARCA biopharma Announces C. Jeff Dekker to be Appointed Chief Financial Officer
Bio-Pharma Stock Market
May 3, 2021

ARCA biopharma Announces C. Jeff Dekker to be Appointed Chief Financial Officer

Denali Therapeutics Presents Positive Results from Phase 1 and Phase 1b Studies of Its LRRK2 Inhibitor, BIIB122/DNL151, Supporting Late-Stage Development Plans in Parkinson’s Disease
Bio-Pharma Business Medical Stock Market Technology
May 2, 2021

Denali Therapeutics Presents Positive Results from Phase 1 and Phase 1b Studies of Its LRRK2 Inhibitor, BIIB122/DNL151, Supporting Late-Stage Development Plans in Parkinson’s Disease

Recent Posts

  • Digital Asset Treasuries: The Lifeline Reshaping Corporate Growth and Biotech Innovation
  • Standard Chartered’s SC Ventures to Launch $250M Crypto Investment Fund in 2026
  • MoonPay Expands Global Reach With Acquisition of Meso
  • New $100M Pro-Crypto Super PAC Launches to Back “Pro-Innovation” Candidates in the U.S
  • Pecu Novus Treasury Strategy: Redefining Startup Finance in the Digital Economy
The UCW Newswire : Blockchain and Crypto News

Copyright UCW Newswire, All Rights Reserved